Q&A: Vectura's Leaders Explain Synergies And Priorities For Merged Company

Vectura's CEO James Ward-Lilley and incoming CFO from Skyepharma, Andrew Derodra, sat down with Scrip and explained where they see the excitement, synchronization and R&D fusion for the larger company.

More from Business

More from Scrip